Navigation Links
Watson First Quarter 2011 Net Revenue Increases to $877 Million
Date:4/27/2011

on of forecasted net income for the twelve months ending December 31, 2011 to non-GAAP net income and non-GAAP earnings per diluted share:Table 6WATSON PHARMACEUTICALS, INC.Reconciliation Table - Forecasted Non-GAAP Earnings per Diluted Share(Unaudited; in millions except per share amounts)Forecast for Twelve Months Ending December 31, 2011LowHighGAAP to non-GAAP net income calculationGAAP net income$
227$
258Adjusted for:Amortization276276Global supply chain initiative1515Acquisition and licensing charges 3434Interest accretion on contingent obligations3838Non-cash impairment charges1414Other (gains) losses(6)(6)Income taxes(99)(99)Non-GAAP net income$
499$
530Diluted earnings per shareDiluted earnings per share - GAAP $
.80$
2.04Diluted earnings per share - Non-GAAP$
3.95$
4.20Diluted weighted average common shares outstanding126.3126.3The reconciliation table is based in part on management's estimate of non-GAAP net income for the year ending December 31, 2011.  Watson expects certain known GAAP charges for 2011, as presented in the schedule above.  Other GAAP charges that may be excluded from non-GAAP net income are possible, but their amounts are dependent on numerous factors that we currently cannot ascertain with sufficient certainty or are presently unknown.  These GAAP charges are dependent upon future events and valuations that have not yet been performed.

The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2011 to adjusted EBITDA:Table 7WATSON PHARMACEUTICALS, INC.Reconciliation Table - Forecasted Adjusted EBITDA(Unaudited; in millions)Forecast for Twelve Months Ending December 31, 2011LowHighGAAP net income$
227$
258Plus:Interest expense8888Interest income(1)(1)Provision for income taxes175194Depreciation (includes accelerated depreciation)102102Amortization276276EBITDA867917Adjusted for:Global supply chain initiative1212Acquisition and licens
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. New Life Agency Adds Watson to Join Walgreens on The Fertility Pharmacy Care Card for Fertility Medication
2. Watson Confirms Welchol® Patent Challenge
3. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
4. Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings
5. Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia
6. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
7. Watson Confirms OxyContin® Patent Challenge
8. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
9. Cephalon Wins FENTORA Patent Suit Against Watson
10. Watson Launches Generic Famvir®
11. Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Quetiapine ... Developed by AstraZeneca plc, quetiapine (under the ... for the treatment of schizophrenia. Approved by CFDA ... in the Catalogue of Drugs for the Basic ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Ranibizumab ... Developed by Novartis, ranibizumab was approved by CFDA to ... Currently, only Lucentis, a product of Novartis, is available ... the first self- developed drug for the treatment of ...
(Date:8/28/2015)... Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... MYL ) shareholder vote regarding its planned unsolicited offer ... offer to Perrigo shareholders have always been, and will ... of the value available to Perrigo shareholders, and do ... allowed its shareholders to consider," said Joseph C. ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... Pharmaceuticals (Nasdaq: ENDP ) announced today the ... President, HealthTronics Inc., effective Aug. 29, 2011. HealthTronics, an ... products and services based in Austin, Texas. ... Group President James Whittenburg, who is staying through the ...
... Aug. 22, 2011 Leatt Corporation, a Nevada corporation ... Leatt-Brace®, a Neck Brace System designed to help prevent ... (neck), as well as other products, today announced that ... Department of Commerce issued a patent for the Leatt ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 3U.S. Patent for Leatt Neck Brace System Issued 2
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of furthering ... the second year to the Adams County Fairgrounds in Mendon, IL on May 30th, ... money to support music education in the underfunded school districts of Mendon and its ...
(Date:8/28/2015)... ... 28, 2015 , ... The 6th Annual Survivor in the City, Chicago ... yet another accolade to its cadre of widespread support—an official letter of support and ... of the medical community and the University of Illinois at Chicago’s Department of Neurosurgery, ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... “ Frequentz ... look at the latest and coolest applications on the market for iOS, Android, and ... and shared with viewers how this software allows businesses to track product movement from ...
(Date:8/28/2015)... TN (PRWEB) , ... August 28, 2015 , ... ... recipients of the Veterans Award, honoring military veterans leading in business. Mr. ... honorees. , The inaugural Nashville Business Journal's 2015 Veterans Awards will ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Quatela Center for Plastic Surgery ... first and only nonsurgical product approved by the Food and Drug Administration to eliminate ... and Dr. William Koenig are among the premier cosmetic surgeons in Rochester ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
... FAIRFAX, Va., June 9 General Dynamics,Information Technology, ... GD ), has,been awarded three task orders by ... Support Wholesale Program (DMLSS-W). The,contracts have a total ... if,all options are exercised., Under these tasks, ...
... cancer are being failed by medical researchers who are ... in mind and who are not recruiting sufficient numbers ... according to new figures announced today (Monday). , Dr ... Cancer Trust,s Fifth International Conference on Teenage and Young ...
... 2008 A 115-year-old woman who remained mentally alert ... little or no evidence of Alzheimer,s disease, according to ... Aging ( http://neurobiologyofaging.org/ ). , The findings question the ... will inevitably develop, if people live long enough. ...
... patients who attended a specialist nurse clinic rather than ... longer, more frequent consultations and good symptom management, according ... Journal of Clinical Nursing. , And because the ... per cent of the consultations without referring issues to ...
... WASHINGTON, June 9 Gentag, Inc. and MacroArray,Technologies, ... design a,wireless immunoassay incorporating Gentag,s cell phone communication,technology ... One in six males are at risk ... are being tested. In order to simplify and ...
... June 9 ATS Medical, Inc.,(Nasdaq: ... cardiac,surgery products and services, today noted that ... experience with ATS Medical products and related,procedures ... International,Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) ...
Cached Medicine News:Health News:General Dynamics Awarded Multiple Contracts to Support Defense Medical Logistics Supply Chain Operations 2Health News:Organizers of cancer clinical trials are neglecting teenagers and young adults 2Health News:Organizers of cancer clinical trials are neglecting teenagers and young adults 3Health News:World's oldest woman had normal brain 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 3Health News:Gentag, Inc. and MacroArray Technologies Join Forces 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 3
... Studies have proven that the management of ... blood glucose levels is the most effective way ... comprehensive care aimed at maintaining or improving a ... complex and costly. , ,These have been ...
... diabetes requires making decisions about insulin dosages ... These decisions are guided by data from ... and by the patterns that can be ... Providers when the data is presented in ...
... Diode Pumped Green Photocoagulator - Portable and ... hospital outpatient clinic, and operating room. Built ... even in the most demanding environments, the ... needs. A full line of accessories ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: